Company Filing History:
Years Active: 2025
Title: Anja Golob Urbanc: Innovator in Cancer Immunology
Introduction
Anja Golob Urbanc is a prominent inventor based in Kranj, Slovenia. She has made significant contributions to the field of cancer immunology through her innovative research and patents. Her work focuses on developing novel therapeutic approaches to enhance the immune response against cancer.
Latest Patents
Anja holds a patent for "Split superantigens and their use for immunotherapy." This invention involves a split superantigen that is divided into two fragments, which do not exhibit biological activity on their own. Only upon dimerization do these fragments regain T cell activity. The invention includes a screening method for detecting effective split superantigen designs, where the fragments are fused with coiled-coil forming peptides. This innovative approach aims to activate T-cell responses specifically targeting tumor antigens.
Career Highlights
Anja is associated with the Kemijski Institut, where she collaborates with other researchers to advance her work in immunotherapy. Her dedication to cancer research has positioned her as a key figure in the scientific community.
Collaborations
Anja collaborates with Roman Jerala, a fellow researcher, to further explore the potential of split superantigens in cancer treatment. Their combined expertise enhances the development of effective immunotherapeutic strategies.
Conclusion
Anja Golob Urbanc's contributions to cancer immunology through her innovative patent demonstrate her commitment to advancing medical science. Her work has the potential to significantly impact cancer treatment and improve patient outcomes.